# Medication in Early Diabetes (MED) Study

> **NCT00437970** · PHASE4 · WITHDRAWN · sponsor: **Menzies School of Health Research**

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00437970
- **Lead sponsor:** Menzies School of Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-04
- **Primary completion:** 2009-01
- **Final completion:** 2009-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to secure supply of the study medication
- **Last updated:** 2016-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00437970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00437970, "Medication in Early Diabetes (MED) Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00437970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*